Centessa Beats Shareholder Suit Over Kidney Drug
By Katryna Perera · August 5, 2024, 4:48 PM EDT
A New York federal judge has tossed a shareholder lawsuit alleging that Centessa Pharmaceuticals PLC overstated the prospects of its kidney disease treatment ahead of the drugmaker's initial public offering, saying...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login